Lang Sheng Investment
Overview
Lang Sheng Investment is a prominent venture capital firm based in Shanghai, China, focusing on early-stage investments in the healthcare and big data sectors. Established in 2010, the firm manages assets totaling approximately RMB 1.3 billion and has invested in over 30 companies, including notable unicorns like Ankon and CapitalBio. The firm's investment strategy emphasizes providing not only capital but also strategic guidance and domain expertise to foster the growth of its portfolio companies. Lang Sheng Investment has a strong track record in sectors such as healthcare, biotechnology, medical devices, pharmaceuticals, and information technology. With a dedicated team of professionals, Lang Sheng Investment continues to support innovative companies, aiming to make a significant impact on the healthcare and big data industries in China and beyond.
Investment Focus
- Innovative business models
- Strong management teams
- Scalable growth potential
Portfolio Companies
Reach Lang Sheng Investment directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Lang Sheng Investment
What sectors does Lang Sheng Investment invest in?
Lang Sheng Investment invests in Healthcare, Software, E-commerce, Logistics, Information Technology and Biotechnology, and is based in Shanghai, China. Lang Sheng Investment is listed as a venture capital in the ConnectSafely investor database.
What stage does Lang Sheng Investment invest at?
Lang Sheng Investment backs companies at Early Stage, Series A, Series B and Growth, writing cheques of 10M - 50M.
Which regions does Lang Sheng Investment invest in?
Lang Sheng Investment invests across United States and China.
What companies has Lang Sheng Investment invested in?
Lang Sheng Investment's portfolio includes Ankon, CapitalBio, WeHand, Svision, DataEye and PrizExpress.
Last updated · Source: ConnectSafely investor database
